Would treatment decisions about secondary prevention of CVD based on estimated lifetime benefit rather than 10-year risk reduction be cost-effective?

by Gijs F. N. Berkelmans, Jacoba P. Greving, Yolanda van der Graaf, Frank L. J. Visseren, Jannick A. N. Dorresteijn
Published 2020-04-01

The Missing Link in the Pathophysiology of Vascular Cognitive Impairment: Design of the Heart-Brain Study

by Astrid M. Hooghiemstra, Anne Suzanne Bertens, Anna E. Leeuwis, Esther E. Bron, Michiel L. Bots, Hans-Peter Brunner-La Rocca, Anton J.M. de Craen, Rob J. van der Geest, Jacoba P. Greving, L. Jaap Kappelle, Wiro J. Niessen, Robert J. van Oostenbrugge, Matthias J.P. van Osch, Albert de Roos, Albert C. van Rossum, Geert Jan Biessels, Mark A. van Buchem, Mat J.A.P. Daemen, Wiesje M. van der Flier
Published 2017-10-01

External Validation of the ELAPSS Score for Prediction of Unruptured Intracranial Aneurysm Growth Risk

by Mayte Sánchez van Kammen, Jacoba P. Greving, Satoshi Kuroda, Daina Kashiwazaki, Akio Morita, Yoshiaki Shiokawa, Toshikazu Kimura, Christophe Cognard, Anne C. Januel, Antti Lindgren, Timo Koivisto, Juha E. Jääskeläinen, Antti Ronkainen, Liisa Pyysalo, Juha Öhman, Melissa Rahi, Johanna Kuhmonen, Jaakko Rinne, Eva L. Leemans, Charles B. Majoie, W. Peter Vandertop, Dagmar Verbaan, Yvo B.W.E.M. Roos, René van den Berg, Hieronymus D. Boogaarts, Walid Moudrous, Ido R. van den Wijngaard, Laura ten Hove, Mario Teo, Edward J. St George, Katharina A.M. Hackenberg, Amr Abdulazim, Nima Etminan, Gabriël J.E. Rinkel, Mervyn D.I. Vergouwen
Published 2019-09-01